Life After s Loss: Impact of Hepatitis B s Antigen Loss on Future Patient Outcomes
Daniel Q. Huang, Seng Gee Lim – 24 May 2021
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable
Radha K. Dhiman, Madhumita Premkumar – 24 May 2021
Heterogeneidad clínica y virológica de la hepatitis delta en la Amazonia: más preguntas que respuestas
Raymundo Paraná, y Flor H. Pujol – 24 May 2021
Affordability of Antiviral Therapy in Asia‐Pacific Countries and Its Impact on Public Health Outcomes
Prowpanga Udompap, Tawesak Tanwandee, Rino Gani – 24 May 2021
PBC: No Longer a Western Disease?
Atsushi Tanaka – 24 May 2021
Insuficiencia hepática aguda secundaria a fiebre amarilla: un escenario complejo
Alice Tung Wan Song, y Luiz Augusto Carneiro D'Albuquerque – 24 May 2021
Preface: A CLD Collaboration With the Latin American Association for the Study of the Liver (ALEH)
Mário G. Pessoa, Manuel Mendizabal – 24 May 2021
Introduction: Liver Disease in Asia
Kazuhiko Koike, W. Ray Kim – 24 May 2021
Cuando la creación de un consorcio proporciona respuestas útiles: experiencia de la Latin American DILI network (LATINDILIN)
Fernando Bessone, Nelia Hernández, Manuel Mendizábal, Adriana Sánchez, Raymundo Paraná, Marco Arrese, Martín Tagle, Marcos Girala, Maribel Lizarzábal, Enrique Carrera, Javier Brahm, Fernando Contreras, Nahum Méndez‐Sánchez, Genario Santos, Vinicius Nunes, Inmaculada Medina‐Cáliz, Cecilio Parra‐Martínez, Laura Sanz‐Villanueva, María Isabel Lucena, Raúl J. Andrade – 24 May 2021
Nonalcoholic Fatty Liver Disease Risk Factors in Latin American Populations: Current Scenario and Perspectives
Claudia Pinto Marques Souza de Oliveira, Helma Pinchemel Cotrim, Marco Arrese – 24 May 2021